Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(Q2)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 32.76%24.96B | 30.57%23.96B | 30.57%23.96B | 60.77%21.85B | 16.20%18.8B | -5.26%19.04B | -37.45%18.35B | -37.45%18.35B | -46.26%13.59B | -33.59%16.18B |
-Cash and cash equivalents | 31.93%22.57B | 29.14%21.76B | 29.14%21.76B | 66.65%20.15B | 23.20%17.1B | 1.40%17.54B | -36.02%16.85B | -36.02%16.85B | -46.23%12.09B | -35.64%13.88B |
-Short term investments | 41.12%2.4B | 46.60%2.2B | 46.60%2.2B | 13.34%1.7B | -26.09%1.7B | -46.43%1.5B | -49.98%1.5B | -49.98%1.5B | -46.46%1.5B | -17.83%2.3B |
Receivables | -25.97%5.05B | -24.15%5B | -24.15%5B | -52.47%5.19B | -30.20%6.82B | -51.06%5.52B | -52.89%6.59B | -52.89%6.59B | -16.49%10.92B | -7.54%9.77B |
-Accounts receivable | -25.97%5.05B | -24.15%5B | -24.15%5B | -52.47%5.19B | -30.20%6.82B | -51.06%5.52B | -52.89%6.59B | -52.89%6.59B | -16.49%10.92B | -7.54%9.77B |
-Gross accounts receivable | -25.97%5.05B | -24.15%5B | -24.15%5B | -52.47%5.19B | -30.20%6.82B | -51.06%5.52B | -52.89%6.59B | -52.89%6.59B | -16.49%10.92B | -7.54%9.77B |
Inventory | -38.86%8B | -23.05%11.08B | -23.05%11.08B | -46.59%11.83B | -41.95%13.08B | -31.50%14.28B | 23.20%14.4B | 23.20%14.4B | 119.03%22.15B | 109.17%22.53B |
Other current assets | -5.90%1.71B | -63.81%1.78B | -63.81%1.78B | -55.91%1.9B | -45.75%1.81B | -17.33%2.1B | 71.03%4.91B | 71.03%4.91B | 153.12%4.3B | 57.12%3.34B |
Total current assets | -1.97%39.71B | -5.50%41.81B | -5.50%41.81B | -20.01%40.77B | -21.82%40.51B | -25.24%40.95B | -23.56%44.25B | -23.56%44.25B | 1.57%50.96B | 8.34%51.82B |
Non current assets | ||||||||||
Net PPE | -11.96%7.38B | -11.87%7.39B | -11.87%7.39B | 2.14%8.51B | 3.84%8.38B | 7.76%8.34B | 8.39%8.38B | 8.39%8.38B | 12.01%8.33B | 7.85%8.07B |
-Gross PP&E | ---- | -1.11%77.69B | -1.11%77.69B | ---- | ---- | ---- | 0.91%78.56B | 0.91%78.56B | ---- | ---- |
-Accumulated depreciation | ---- | -0.17%-70.3B | -0.17%-70.3B | ---- | ---- | ---- | -0.09%-70.18B | -0.09%-70.18B | ---- | ---- |
Total investment | -8.02%24.52B | -7.18%23.69B | -7.18%23.69B | 6.28%24.61B | 13.74%26.66B | 9.67%26.69B | 6.76%25.52B | 6.76%25.52B | -4.24%23.15B | 7.23%23.44B |
-Financial asset investment | -8.02%24.52B | -7.18%23.69B | -7.18%23.69B | 6.28%24.61B | 13.74%26.66B | 9.67%26.69B | 6.76%25.52B | 6.76%25.52B | -4.24%23.15B | 7.23%23.44B |
-Including:Available-for-sale securities | -8.02%24.52B | -7.18%23.69B | -7.18%23.69B | 6.28%24.61B | 13.74%26.66B | 9.67%26.69B | 6.76%25.52B | 6.76%25.52B | -4.24%23.15B | 7.23%23.44B |
Goodwill and other intangible assets | -96.56%10M | 19.25%285M | 19.25%285M | 29,900.00%300M | 29,000.00%291M | 26,900.00%270M | 23,800.00%239M | 23,800.00%239M | 0.00%1M | --1M |
Defined pension benefit | 87.97%500M | 140.40%476M | 140.40%476M | --277M | --266M | --232M | --198M | --198M | ---- | ---- |
Other non current assets | 72.73%323M | -42.44%137M | -42.44%137M | -36.86%161M | -33.69%187M | -29.84%214M | -28.10%238M | -28.10%238M | -27.97%255M | -25.59%282M |
Total non current assets | -8.52%32.74B | -7.53%31.97B | -7.53%31.97B | 6.66%33.85B | 12.55%35.79B | 10.39%35.75B | 8.15%34.58B | 8.15%34.58B | -0.72%31.74B | 6.97%31.8B |
Total assets | -5.04%72.46B | -6.39%73.79B | -6.39%73.79B | -9.77%74.62B | -8.75%76.3B | -12.00%76.7B | -12.27%78.83B | -12.27%78.83B | 0.68%82.7B | 7.82%83.62B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -23.50%511M | -63.36%281M | -63.36%281M | -77.08%348M | -64.35%668M | -67.74%380M | -67.60%767M | -67.60%767M | 2.29%1.52B | 51.01%1.87B |
-accounts payable | -25.24%465M | -69.21%234M | -69.21%234M | -78.64%324M | -57.83%622M | -59.64%354M | -43.33%760M | -43.33%760M | 43.79%1.52B | 37.85%1.48B |
-Total tax payable | 0.00%46M | 571.43%47M | 571.43%47M | 2,300.00%24M | -88.47%46M | -91.36%26M | -99.32%7M | -99.32%7M | -99.77%1M | 133.33%399M |
Current provisions | ---- | --5M | --5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Pension and other retirement benefit plans | -31.90%111M | 23.16%117M | 23.16%117M | 38.71%43M | -26.24%163M | 48.00%185M | -78.60%95M | -78.60%95M | -47.46%31M | -27.06%221M |
Accrued and deferred income | -14.58%879M | -12.38%892M | -12.38%892M | -38.77%908M | -22.98%1.03B | -42.77%883M | -42.19%1.02B | -42.19%1.02B | -17.88%1.48B | 0.15%1.34B |
Other current liabilities | 88.46%441M | -42.49%379M | -42.49%379M | -54.48%381M | -64.00%234M | -21.82%448M | -29.59%659M | -29.59%659M | -4.56%837M | 145.28%650M |
Current liabilities | -7.26%1.94B | -34.07%1.67B | -34.07%1.67B | -56.58%1.68B | -48.69%2.09B | -44.55%1.9B | -53.90%2.54B | -53.90%2.54B | -8.45%3.87B | 29.84%4.08B |
Non current liabilities | ||||||||||
Long term provisions | -2.42%1.29B | -12.37%1.29B | -12.37%1.29B | 0.92%1.32B | 2.80%1.32B | 5.03%1.42B | 9.37%1.47B | 9.37%1.47B | -4.24%1.31B | -6.00%1.29B |
Long term pension and other post-retirement benefit plans | 14.55%63M | 18.00%59M | 18.00%59M | 107.41%56M | -5.17%55M | -41.11%53M | -59.02%50M | -59.02%50M | -94.21%27M | -88.40%58M |
Non current deferred liabilities | -41.76%1.57B | -38.12%1.68B | -38.12%1.68B | -15.18%2.1B | 28.34%2.7B | 10.96%2.77B | 0.37%2.72B | 0.37%2.72B | 7.95%2.47B | 4.21%2.1B |
Other non current liabilities | -13.79%25M | 80.00%27M | 80.00%27M | 100.00%28M | 93.33%29M | 87.50%30M | -6.25%15M | -6.25%15M | -17.65%14M | 0.00%15M |
Total non current liabilities | -28.14%2.95B | -28.14%3.06B | -28.14%3.06B | -8.38%3.5B | 18.58%4.1B | 8.06%4.28B | 1.50%4.25B | 1.50%4.25B | -7.68%3.82B | -11.26%3.46B |
Total liabilities | -21.09%4.89B | -30.35%4.73B | -30.35%4.73B | -32.63%5.18B | -17.82%6.2B | -16.32%6.17B | -29.96%6.79B | -29.96%6.79B | -8.07%7.69B | 7.09%7.54B |
Shareholders'equity | ||||||||||
Share capital | 0.00%13.92B | 0.00%13.92B | 0.00%13.92B | 0.00%13.92B | 0.00%13.92B | 0.00%13.92B | 0.00%13.92B | 0.00%13.92B | 0.00%13.92B | 0.00%13.92B |
-common stock | 0.00%13.92B | 0.00%13.92B | 0.00%13.92B | 0.00%13.92B | 0.00%13.92B | 0.00%13.92B | 0.00%13.92B | 0.00%13.92B | 0.00%13.92B | 0.00%13.92B |
Additional paid-in capital | 0.00%3.48B | 0.00%3.48B | 0.00%3.48B | 0.00%3.48B | 0.00%3.48B | 0.00%3.48B | 0.00%3.48B | 0.00%3.48B | 0.00%3.48B | 0.00%3.48B |
Retained earnings | -0.31%47.78B | -1.75%49.66B | -1.75%49.66B | -10.62%48.6B | -14.10%47.93B | -16.78%48.97B | -13.74%50.54B | -13.74%50.54B | 0.03%54.37B | 9.48%55.8B |
Less: Treasury stock | 0.00%452M | 0.00%452M | 0.00%452M | 0.00%452M | 0.22%452M | 0.22%452M | 0.44%452M | 0.44%452M | 0.44%452M | 0.22%451M |
Fixed asset revaluation reserve | -32.55%400M | -32.55%400M | -32.55%400M | -3.37%573M | 0.00%593M | 0.00%593M | 0.00%593M | 0.00%593M | 0.00%593M | -8.06%593M |
Other reserves | -49.76%2.19B | -51.49%1.78B | -51.49%1.78B | 8.35%3.05B | 77.45%4.37B | 19.65%3.72B | -1.85%3.66B | -1.85%3.66B | 76.10%2.81B | 47.90%2.46B |
Total stockholders'equity | -3.60%67.33B | -4.13%68.79B | -4.13%68.79B | -7.44%69.17B | -7.87%69.84B | -11.66%70.24B | -10.17%71.75B | -10.17%71.75B | 1.68%74.73B | 7.94%75.8B |
Noncontrolling interests | -10.53%238M | -4.53%274M | -4.53%274M | -4.20%274M | -4.32%266M | 4.36%287M | 0.00%287M | 0.00%287M | -0.35%286M | -4.14%278M |
Total equity | -3.63%67.56B | -4.13%69.06B | -4.13%69.06B | -7.43%69.44B | -7.85%70.11B | -11.60%70.52B | -10.13%72.03B | -10.13%72.03B | 1.67%75.02B | 7.89%76.08B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |